CBD (Cannabidiol)
CBD is a genuinely effective prescription anticonvulsant at 10-20 mg/kg/day — but the evidence for the reasons people actually buy it, anxiety, sleep and pain, is thin and inconsistent, and typical over-the-counter doses of 10-50 mg are far below anything ever shown to work. Product mislabelling is rampant.
What the science says
- Reduces seizures in Dravet and Lennox-Gastaut syndromes Strong evidence
In a randomised, double-blind trial of 120 children and young adults with Dravet syndrome, CBD 20 mg/kg/day cut median monthly convulsive seizures from 12.4 to 5.9, versus 14.9 to 14.1 on placebo. Replicated trials led to regulatory approval of pharmaceutical CBD (Epidiolex/Epidyolex) — this is a prescription medicine at doses roughly 20-100 times what consumer products contain.
- Reduces anxiety Limited evidence
A systematic review of randomised trials in anxiety found a small, heterogeneous literature dominated by single-dose experimental studies using 300-600 mg CBD in laboratory-induced anxiety, such as simulated public speaking. Trials of repeated dosing in diagnosed anxiety disorders are few and results are inconsistent, and no trial supports the 10-25 mg doses typical of retail gummies and oils.
- Improves sleep Limited evidence
Sleep is usually a secondary outcome in CBD trials, and reviews of non-seizure indications find no consistent benefit for insomnia. Where sleep improves, it often tracks improvement in the primary condition such as pain or anxiety rather than a direct hypnotic effect.
- Relieves chronic pain Limited evidence
Systematic reviews of randomised trials of CBD alone for chronic pain report little consistent separation from placebo. Much of the positive cannabis pain literature involves THC-containing preparations, which is a different question entirely.
Dosage & safety
How to take it
Interactions
With medications
- clobazam
CBD raises levels of clobazam's active metabolite substantially, increasing sedation. do not combine without your neurologist adjusting the clobazam dose
- valproate
Liver transaminase elevations are markedly more common on the combination. do not combine without liver function monitoring
- warfarin
CBD inhibits CYP2C9 and raises INR. do not combine without INR monitoring arranged in advance
- drugs metabolised by CYP3A4 or CYP2C19
CBD inhibits both and can raise levels of a wide range of prescription drugs. check your full medication list with a pharmacist before starting
With other supplements
- melatonin, valerian and other sedating supplements
Additive somnolence and fatigue. add one at a time
Well-established interactions only — this is not a complete list. Always tell your doctor and pharmacist what you take.
Frequently asked questions
Does CBD work for anxiety?
The evidence for CBD in anxiety is limited: most studies used single 300-600 mg doses in laboratory-induced anxiety, and trials in diagnosed anxiety disorders are few and inconsistent. No trial supports the 10-25 mg doses in typical retail gummies and oils.
Does CBD help with sleep or chronic pain?
Reviews find no consistent benefit of CBD for insomnia, and trials of CBD alone for chronic pain show little separation from placebo. Where sleep improves, it often follows improvement in pain or anxiety rather than a direct effect.
Does CBD actually work for anything?
Yes, for seizures: strong evidence shows prescription CBD at 10-20 mg/kg/day reduces seizures in Dravet and Lennox-Gastaut syndromes, and in one trial cut median monthly seizures from 12.4 to 5.9. Those doses are roughly 20-100 times what consumer CBD products contain.
Does CBD interact with medications?
Yes: CBD inhibits CYP3A4 and CYP2C19, raises levels of clobazam's active metabolite and warfarin, and causes more liver enzyme elevations with valproate. Check your full medication list with a pharmacist before starting CBD.
Scientific references
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- The Impact of Cannabidiol Treatment on Anxiety Disorders: A Systematic Review of Randomized Controlled Clinical Trials
- Adverse Effects of Oral Cannabidiol: An Updated Systematic Review of Randomized Controlled Trials (2020-2022)
Where to buy
Ships to 180+ countries · welcome discount for new customers
Referral link — this site may earn a commission on purchases.
Related in Stress & mood
- Ashwagandha Moderate evidence
- L-Methylfolate Limited evidence
- 5-HTP Limited evidence
- L-Ornithine Limited evidence
- SAM-e Moderate evidence
- Rhodiola Rosea Limited evidence